Archive for November, 2008
Half of nation’s docs want to quit, survey says
by andreas on Nov.27, 2008, under Uncategorized
Nearly half the respondents in a survey of U.S. primary care physicians said that they would seriously consider getting out of the medical business within the next three years if they had an alternative. Many said they are overwhelmed with red tape from insurance companies and government agencies.
FDA Scientists Revolt Against Corrupt Food & Drug Officials
by andreas on Nov.27, 2008, under Uncategorized
A group of scientists working in the FDA
’s Center for Devices and Radiological Health division has revolted against the corrupt managers of its own department, accusing them of committing crimes by claiming, “There is extensive documentary evidence that managers at CDRH have corrupted and interfered with the scientific review of medical devices.”
Bayer to pay $97.5M to settle kickback probe
by andreas on Nov.27, 2008, under Uncategorized
German medical conglomerate Bayer will pay $97.5 million to settle U.S. government allegations that it paid kickbacks to medical suppliers to boost sales of its diabetes products.
Opponents brace for end of stem cell ban
by andreas on Nov.26, 2008, under Uncategorized
President-elect Barack Obama could reignite an emotional national debate over the promise and the perils of medical research using cells taken from human embryos.
The United States Conference of Catholic Bishops is warning that Obama will alienate millions, and abortion opponents are bracing for a fight. Medical researchers, meanwhile, are rejoicing at the prospect of freedom from a government policy they say has stymied efforts to develop life-saving treatments.
Like previous presidents, Obama is expected to issue a flurry of executive orders after he takes office Jan. 20. Some could reverse Bush administration policies; others could promote his own.
VeriChip Now Monitoring Diabetes With RFID Microchips
by andreas on Nov.25, 2008, under diabetes
When the US Food & Drug Administration approved implanting microchips in humans, the manufacturer said it would save lives, letting doctors scan the tiny transponders to access patients’ medical records almost instantly. “The glucose sensor is a promising example, combining a unique application of the technology and an extremely valuable market.”